1. Home
  2. Analysis
  3. Cefdinir
  4. Odefsey

Cefdinir and Odefsey drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate). Common drug interactions include anhedonia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Odefsey. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Odefsey?

Odefsey has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 4,605 Odefsey users. Check the latest studies of Odefsey.

On Jul, 27, 2026

12 people who take Cefdinir and Odefsey together, and have interactions are studied.

Cefdinir and Odefsey drug interactions.

What are the common drug interactions of Cefdinir and Odefsey, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Decreased activity
  6. Fatigue (feeling of tiredness)
  7. Quality of life decreased
  8. Renal failure (kidney dysfunction)
  9. Renal transplant
  10. Bone density decreased

male:

  1. Anxiety
  2. Emotional distress
  3. Hydronephrosis (water inside the kidney)
  4. Hypertension (high blood pressure)
  5. Renal cyst (kidney cyst)
  6. Arthralgia (joint pain)
  7. Blood creatinine increased
  8. Bone loss
  9. Dysstasia (difficulty in standing)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Cefdinir and Odefsey, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Decreased activity
  4. Emotional distress
  5. Fatigue (feeling of tiredness)
  6. Pain
  7. Quality of life decreased
  8. Renal failure (kidney dysfunction)
  9. Renal transplant

40-49:

  1. Anxiety
  2. Emotional distress
  3. Pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Bone density decreased
  6. Decreased activity
  7. Fatigue (feeling of tiredness)
  8. Quality of life decreased
  9. Renal failure (kidney dysfunction)
  10. Renal transplant

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Bone density decreased
  7. Exercise tolerance decreased
  8. Gait disturbance
  9. Haematuria (presence of blood in urine)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal cyst (kidney cyst)
  4. Asthenia (weakness)
  5. Chronic kidney disease
  6. Emotional distress
  7. Pain
  8. Renal impairment (severely reduced kidney function)
  9. Glomerular filtration rate decreased
  10. Hydronephrosis (water inside the kidney)

What are the existing conditions these people have? *

  1. Infection: 3 people, 25.00%
  2. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 25.00%
  3. Hypersensitivity: 3 people, 25.00%
  4. High Blood Pressure: 3 people, 25.00%
  5. Erection Problems: 3 people, 25.00%
  6. Cough: 3 people, 25.00%
  7. Breast Cancer: 3 people, 25.00%
  8. Bacterial Infection: 3 people, 25.00%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 25.00%
  10. Acne (skin problems that cause pimples): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Odefsey?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Odefsey:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Odefsey:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Odefsey and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate (the active ingredients of Cefdinir and Odefsey, respectively), and Cefdinir and Odefsey (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.